Clinical Trial Update: Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians

View source ↗

Summary

A completed clinical trial assessing the place of Flixovate in the treatment pathway and conditions of use for atopic dermatitis in infants aged 3 to 12 months,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Flixovate

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dermatitis, Atopic | Status: COMPLETED